Surgery for Parkinson's shown to have long-term benefits
This article was originally published in Clinica
Executive Summary
Patients with advanced Parkinson's disease treated surgically by unilateral pallidotomy continue to show improvement five years after the procedure, according to a study reported in the New England Journal of Medicine (June 8). The study's follow-up period is the longest yet to be reported in the literature.
You may also be interested in...
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.